OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase (OxyGap)

April 3, 2023 updated by: François Lellouche, Laval University

OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood

The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign.

Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy.

Thus, this study aims to compare the SpO2 values of different oximeters (Nonin, Masimo, Philips, Nellcor) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Quebec, Canada, G1V4G5
        • Recruiting
        • Institut universitaire de Cardiologie et de Pneumologie de Quebec
    • Quebec
      • Montréal, Quebec, Canada, H2X0A9
        • Not yet recruiting
        • CHUM
        • Contact:
          • Emmanuel Charbonney

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patient in ICU with arterial catheter already installed will be consider.

Description

Inclusion Criteria:

  • ≥ 18 years old
  • Patients admitted to the Intensive Care Unit
  • Artery catheter already installed

Exclusion Criteria:

  • No signal with the oximeter
  • Pigmented nails or nail polish
  • Methemoglobinemia
  • Patient in isolation (multi-resistant bacteria, C-Difficile, COVID-19…)
  • Prone position

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diffence between Nellcor SpO2 and the SaO2 value
Time Frame: During arterial blood gase sample
Diffence between Nellcor oximeter SpO2 and the SaO2 value
During arterial blood gase sample
Diffence between FreeO2 SpO2 and the SaO2 value
Time Frame: During arterial blood gase sample
Diffence between Nonin (FreeO2) oximeter SpO2 and the SaO2 value
During arterial blood gase sample
Diffence between Nonin ear clip and the SaO2 value
Time Frame: During arterial blood gase sample
Diffence between Nonin (ear sensor) oximeter SpO2 and the SaO2 value
During arterial blood gase sample
Diffence between Masimo SpO2 and the SaO2 value
Time Frame: During arterial blood gase sample
Diffence between Masimo oximeter SpO2 and the SaO2 value
During arterial blood gase sample
Diffence between Philips SpO2 and the SaO2 value
Time Frame: During arterial blood gase sample
Diffence between Philips oximeter SpO2 and the SaO2 value
During arterial blood gase sample
Diffence between Contec SpO2 and the SaO2 value
Time Frame: During arterial blood gase sample
Difffence between Contec oximeter SpO2 and the SaO2 value
During arterial blood gase sample
Diffence between Bejing choice SpO2 and the SaO2 value
Time Frame: During arterial blood gase sample
Diffence between Bejing choice oximeter SpO2 and the SaO2 value
During arterial blood gase sample

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overestimation and underestimation of SaO2
Time Frame: During arterial blood gase sample
% of pairs with overestimation and underestimation of SaO2 for each oximeter.
During arterial blood gase sample
Hypoxemia detection
Time Frame: During arterial blood gase sample
Ability to detect hypoxemia (SpO2 below 90% and PaO2 < 60 mmHg)
During arterial blood gase sample
Hyperoxemia detection
Time Frame: During arterial blood gase sample
Ability to detect hyperoxemia (SpO2 above 95% and PaO2 > 100 mmHg)
During arterial blood gase sample
Gaps between the different oximeters
Time Frame: During arterial blood gase sample
Average of the SpO2 value gaps between the different oximeters tested
During arterial blood gase sample
Finger and ear sensor comparison
Time Frame: During arterial blood gase sample
Comparison of the finger sensor and ear clip sensor for Nonin oximeter
During arterial blood gase sample

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2021

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

June 30, 2024

Study Registration Dates

First Submitted

February 17, 2021

First Submitted That Met QC Criteria

February 22, 2021

First Posted (Actual)

February 26, 2021

Study Record Updates

Last Update Posted (Actual)

April 5, 2023

Last Update Submitted That Met QC Criteria

April 3, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on SpO2 and SaO2 comparison

3
Subscribe